U.S. Health Secretary Robert F. Kennedy Jr. has named eight new members to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), following the abrupt dismissal of all 17 prior members. The newly appointed panel includes several figures known for expressing skepticism about vaccines, particularly mRNA technology.
Among the new appointees is Robert Malone, a vocal critic of mRNA COVID-19 vaccines and an ally of Kennedy’s "Make America Healthy Again" movement. Other members include Joseph Hibbeln, Martin Kulldorff, Retsef Levi, Cody Meissner, James Pagano, Vicky Pebsworth, and Michael Ross—some of whom have ties to prior CDC or FDA vaccine panels, while others have promoted views critical of current vaccination practices.
Kennedy, who has long challenged vaccine safety despite scientific consensus, claimed the former panel had conflicts of interest, although he did not provide specific evidence. He emphasized the reshuffle was meant to “restore public trust in vaccine science.”
The new ACIP members will participate in the committee’s June 25–27 meeting, where decisions are expected on vaccine recommendations for flu shots and the 2025–26 COVID-19 boosters. The meeting agenda has yet to be released.
The move sparked market reactions: Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) shares dipped slightly, while Novavax (NASDAQ:NVAX), which produces a non-mRNA COVID-19 vaccine, saw a marginal rise.
Concerns remain about the vetting process for the new members. Some, like Pebsworth and Meissner, have served on FDA advisory committees, while others, such as Levi and Kulldorff, have made controversial statements questioning mRNA vaccine safety.
Despite FDA confirmation that mRNA vaccines are safe and effective, Kennedy’s overhaul has intensified the national debate on vaccine policy and public health strategy.


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Trump Says U.S.–Iran Talks Continue as Military Tensions Remain High
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Laura Fernandez Set to Become Costa Rica’s Next President, Promising Sweeping Political Change
Trump Spoke With FBI Agents After Georgia Election Office Search, Report Says
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Japan Election Poll Signals Landslide Win for Sanae Takaichi, Raising Fiscal Policy Concerns
Russian Missile and Drone Attacks Hit Kyiv and Other Ukrainian Cities, Causing Widespread Damage
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Bill and Hillary Clinton Agree to Testify in Epstein Investigation
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Venezuela and U.S. Move Toward Renewed Diplomatic Relations
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Democrats Score Surprise Texas State Senate Win, Fueling Momentum Ahead of 2026 Midterms 



